MAM
NUVB icon

Marquette Asset Management’s Nuvation Bio NUVB Stock Holding History

Marquette Asset Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-56,114
Closed -$149K – 184
2024
Q4 		$149K Hold
56,114
– – 0.02% 106
2024
Q3 		$129K Sell
56,114
-9,923
-15% -$30.3K 0.02% 121
2024
Q2 		$193K Sell
66,037
-31,704
-32% -$96.7K 0.03% 73
2024
Q1 		$356K Sell
97,741
-14,018
-13% -$26.9K 0.06% 58
2023
Q4 		$169K Buy
111,759
+46,369
+71% +$59.7K 0.03% 81
2023
Q3 		$87.6K Hold
65,390
– – 0.02% 112
2023
Q2 		$118K Buy
+65,390
New +$111K 0.03% 104

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Marquette Asset Management's NUVB Position: Q1 2025 in Review

Marquette Asset Management sold out of Nuvation Bio (NUVB) in Q1 2025, closing a stake of 56,114 shares — an estimated $149K sold.

Marquette Asset Management first reported a position in NUVB in Q2 2023 and held it in 7 quarters. The position peaked at $356K in Q1 2024. 161 funds tracked by Wall St. Rank hold NUVB as of Q1 2025.

  • Marquette Asset Management reported no remaining Nuvation Bio position as of Q1 2025 after selling out during the quarter.
  • Marquette Asset Management sold 56,114 Nuvation Bio shares in Q1 2025, an estimated $149K.
  • Marquette Asset Management first reported a position in Nuvation Bio in Q2 2023 and held it in 7 quarters.
  • Marquette Asset Management's Nuvation Bio position peaked at $356K in Q1 2024.
  • 161 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2025.

Based on Marquette Asset Management's 13F filing for Q1 2025, filed 9 Apr 2025.